In the present study, we could create some evidence from human data that an enhanced TGF-β system activity may critically mediate the imbalance of neuroregenerative and neurodegenerative processes in ALS (Figure 13). This evidence concerns the gene TGFB1 and amyotrophic lateral sclerosis.